A company focused on discovering membrane-permeable and orally available cyclic-peptides, taking a mission-driven approach.

INSAMO

Insamo

Please join Insamo CEO Tim Craven in a conversation about "Undruggable Targets and the Advent of Generative AI" at SynBioBeta 2024, happening on May 7th from 2:45 to 3:30 pm. We're diving deep into how generative AI is revolutionizing the hunt for new small molecule targets, especially those in previously inaccessible areas of biology. This session promises to be a fascinating exploration of the interface between advanced computing and biotechnology, showcasing how AI-driven approaches are opening doors to new therapeutic possibilities. We'll discuss the challenges, breakthroughs, and ethical considerations of using AI to navigate the complex landscape of 'undruggable' targets, highlighting the potential for significant medical advancements.

#SynBioBeta2024

#Artificialintelligence is bridging the gap between #syntheticbiology and #medicine - Meet the innovative #companies leading the way: GRO Biosciences, Absci, Generate:Biomedicines, Insamo, Arvinas, Atomwise, Exscientia, Collaborative Drug Discovery - CDD Vault, CellVoyant, Asimov, Alltrna, BioLoomics, Inc., BigHat Biosciences, LabGenius, Profluent Bio, Arzeda, Dreamfold, VantAI, Hexagon Bio, bitBiome, Inc., Enveda Biosciences: https://lnkd.in/gTjz9aEd #SynBioBeta2024 #synbio #AI Thank you to Jenna Gallegos

IPhone / Mobile Compatible

Viewport Meta

SSL by Default

HSTS

Amazon

Google Apps for Business

GStatic Google Static Content

GoDaddy DNS

AWS Global Accelerator

Slack

Matt Hershenson

Corey Goodman

Timothy Craven

Co-founder and CEO

Toby Passioura

Co-Founder and CSO

Life Science Companies With Fewer Than 50 Employees

Pharmaceutical Companies (Top 10K)

California Biotechnology Companies

venBio Partners Portfolio Companies

Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which  lies in its automated process of designing, synthesizing, and testing at an unprecedented scale.

Seed Round - Insamo

Berkeley

California

United States

North America

Insamo Raises $12M in Seed Funding

Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to Develop Best-in ...

Insamo emerges with $12M for membrane-permeable peptide approach

Insamo Launches with $12M Funding

Exclusive: Dupixent in a pill? Startup Insamo will try to turn blockbuster biologics into orals

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Jul 23, 2024 12:20 AM	b2ef6d91
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	5559ed99
crunchbase profile	general	Oct 31, 2024 1:23 AM	f153971c
li profile	general	Jul 23, 2024 12:20 AM	e443ce5b
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	8c022e89
peers	general	Jul 23, 2024 12:20 AM	67f39759
news basic	general	Jul 23, 2024 12:20 AM	a567aed1
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

INSA

COM:INSAMO

INSAMO